Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By activating these https://laylaxczl401534.blogdal.com/36723177/retatrutide-a-promising-new-treatment-for-obesity